Draper Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History
Draper Asset Management, LLC
- $128 Million
- Q1 2025
A detailed history of Draper Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Draper Asset Management, LLC holds 6,431 shares of VRTX stock, worth $2.96 Million. This represents 2.43% of its overall portfolio holdings.
Number of Shares
6,431
Previous 6,333
1.55%
Holding current value
$2.96 Million
Previous $2.55 Million
22.24%
% of portfolio
2.43%
Previous 1.67%
Shares
8 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.82 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.7 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.43 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...